In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.

Documenti analoghi

• Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
  di: Pankuch, G A, et al.
  Pubblicazione: (1993)
• Penetration of ciprofloxacin and fleroxacin into biliary tract.
  di: Edmiston, C E, et al.
  Pubblicazione: (1996)
• Activity of Bay y3118 against quinolone-susceptible and -resistant gram-negative and gram-positive bacteria.
  di: Piddock, L J, et al.
  Pubblicazione: (1994)
• Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens
  Pubblicazione: (1994)
• Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin.
  di: Carlyn, C J, et al.
  Pubblicazione: (1995)